Pfizer Ventures

Sobre

Pfizer Ventures is Pfizer’s strategic corporate venture arm. It invests globally from Seed through IPO, with a strong emphasis on early-stage biopharmaceutical companies developing transformative therapeutics and platform technologies in Pfizer’s core disease areas. Typical initial investments are $5 million–$20 million, and the team can lead or join syndicates.

Sectores

• Ciencias de la vida

Inversiones destacadas

• BioNTech
• Kymera Therapeutics
• SpringWorks Therapeutics
• Nimbus Therapeutics
• Arrakis Therapeutics
• Artios Pharma
• Kestrel Therapeutics
• ReCode Therapeutics
• Anaveon

Inversores

• Michael C. DiemSenior Managing Partner→
• Rana Al-HallaqPartner→
• Irena MelnikovaPartner→
• Christopher O'DonnellPartner→
• Marie-Claire PeakmanPartner→
• Anthony BarryPartner→
• Jiaping GuPartner→

Cómo contactarlos

https://www.pfizer.com/about/partners/submit-your-opportunities